Strategies to increase the efficacy of using gut microbiota for the modulation of obesity

Obesity Reviews

Volumn 18, Issue 11, 2017, Pages 1260-1271

  Li, J ^a   Riaz Rajoka, M S ^a   Shao, D ^a   Jiang, C ^a   Jin, M ^a   Huang, Q ^a   Yang, H ^a   Shi, J ^a  

^a NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

Author keywords

Gut microbiota; intervention; obesity; precision medicine

Indexed keywords

ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

AGE; BARIATRIC SURGERY; CLIMATE; DIET THERAPY; FECAL MICROBIOTA TRANSPLANTATION; GENDER; GEOGRAPHY; HEREDITY; HUMAN; INTESTINE FLORA; LIFESTYLE; NONHUMAN; OBESITY; REVIEW; TREATMENT RESPONSE; DIET; ENVIRONMENTAL MICROBIOLOGY; FECES; GASTROINTESTINAL TRACT; MICROBIOLOGY; SEX FACTOR;

AGE FACTORS; ANTI-BACTERIAL AGENTS; BARIATRIC SURGERY; DIET; ENVIRONMENTAL MICROBIOLOGY; FECES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; LIFE STYLE; OBESITY; PREBIOTICS; PROBIOTICS; SEX FACTORS;

EID: 85030664667     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12590     Document Type: Review

References (158)

1. Collaboration NCDRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. The Lancet 387: 1377–1396.
2. Sonnenburg JL, Backhed F. Diet–microbiota interactions as moderators of human metabolism. Nature 2016; 535: 56–64.
3. Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. 2016; 535: 65–74.
4. Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011; 11: 886–895.
5. Yoshimoto S, Loo TM, Atarashi K et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499: 97–101.
6. Font-Burgada J, Sun B, Karin M. Obesity and cancer: the oil that feeds the flame. Cell Metab 2016; 23: 48–62.
7. Schroeder BO, Backhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 2016; 22: 1079–1089.
8. Venkataraman A, Sieber JR, Schmidt AW, Waldron C, Theis KR, Schmidt TM. Variable responses of human microbiomes to dietary supplementation with resistant starch. Microbiome 2016; 4: 33.
9. Burcelin R. Gut microbiota and immune crosstalk in metabolic disease. Molecular Metabolism. 2016; 5: 771–781.
10. Perry RJ, Peng L, Barry NA et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature 2016; 534: 213–217.
11. Jia W, Li H, Zhao L, Nicholson JK. Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 2008; 7: 123–129.
12. Zhao L. The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 2013; 11: 639–647.
13. Komaroff AL. The microbiome and risk for obesity and diabetes. JAMA. 2017; 317: 355–356.
14. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489: 220–230.
15. Lagier J-C, Million M, Hugon P, Armougom F, Raoult D. Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol 2012; 136.
16. Liang X, Bushman Frederic D, FitzGerald GA. Time in motion: the molecular clock meets the microbiome. Cell 2014; 159: 469–470.
17. Rampelli S, Candela M, Turroni S et al. Microbiota and lifestyle interactions through the lifespan. Trends Food Sci Technol 2016; 57(Part B): 265–272.
18. Falony G, Joossens M, Vieira-Silva S et al. Population-level analysis of gut microbiome variation. Science 2016; 352: 560.
19. Charbonneau MR, Blanton LV, DiGiulio DB et al. A microbial perspective of human developmental biology. Nature 2016; 535: 48–55.
20. Wu GD, Chen J, Hoffmann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science (New York, NY) 2011; 334: 105–108.
21. Muegge BD, Kuczynski J, Knights D et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science (New York, NY) 2011; 332: 970–974.
22. Cotillard A, Kennedy SP, Kong LC et al. Dietary intervention impact on gut microbial gene richness. Nature 2013; 500: 585–588.
23. David LA, Maurice CF, Carmody RN et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559–563.
24. Bäckhed F, Ding H, Wang T et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101: 15718–15723.
25. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027–1131.
26. Mozaffarian D. Foods, obesity, and diabetes – are all calories created equal? Nutr Rev 2017; 75: 19–31.
27. Cockburn DW, Koropatkin NM. Polysaccharide degradation by the intestinal microbiota and its influence on human health and disease. J Mol Biol 2016; 428: 3230–3252.
28. Deehan EC, Walter J. The fiber gap and the disappearing gut microbiome: implications for human nutrition. Trends Endocr Metab 2016; 27: 239–242.
29. Rabot S, Membrez M, Blancher F et al. High fat diet drives obesity regardless the composition of gut microbiota in mice. Sci Rep 2016; 32484.
30. Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani Patrice D, Bäckhed F. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab 2015; 22: 658–668.
31. De Filippis F, Pellegrini N, Vannini L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2015.
32. Holmes AJ, Chew YV, Colakoglu F et al. Diet–microbiome interactions in health are controlled by intestinal nitrogen source constraints. Cell Metab 2017; 25: 140–151.
33. Portune KJ, Beaumont M, Davila A-M, Tomé D, Blachier F, Sanz Y. Gut microbiota role in dietary protein metabolism and health-related outcomes: the two sides of the coin. Trends Food Sci Technol 2016; 57(Part B): 213–232.
34. Thaiss CA, Itav S, Rothschild D et al. Persistent microbiome alterations modulate the rate of post-dieting weight regain. Nature 2016; 540: 544–551.
35. Amiot MJ, Riva C, Vinet A. Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review. Obes Rev 2016; 17: 573–586.
36. Sung MM, Kim TT, Denou E et al. Improved glucose homeostasis in obese mice treated with resveratrol is associated with alterations in the gut microbiome. Diabetes 2017; 66: 418.
37. Liu Z, Chen Z, Guo H et al. The modulatory effect of infusions of green tea, oolong tea, and black tea on gut microbiota in high-fat-induced obese mice. Food Funct 2016; 7: 4869–4879.
38. Huang J, Lin X, Xue B et al. Impact of polyphenols combined with high-fat diet on rats' gut microbiota. J Funct Foods 2016; 26: 763–771.
39. Rial SA, Karelis AD, Bergeron K-F, Mounier C. Gut microbiota and metabolic health: the potential beneficial effects of a medium chain triglyceride diet in obese individuals. Nutrients 2016.
40. Pietiläinen KH, Saarni SE, Kaprio J, Rissanen A. Does dieting make you fat? A twin study. Int J Obes (Lond) 2012; 36: 456–464.
41. Anastasiou CA, Karfopoulou E, Yannakoulia M. Weight regaining: From statistics and behaviors to physiology and metabolism. Metabolism 2015; 64: 1395–1407.
42. Fetissov SO. Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour. Nat Rev Endocrinol 2017; 13: 11–25.
43. Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol 2016; 185.
44. Frost G, Sleeth ML, Sahuri-Arisoylu M et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun 2014; 5: 3611.
45. Chassaing B, Koren O, Goodrich JK et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015; 519: 92–96.
46. Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz AT. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut 2017. https://doi.org/10.1136/gutjnl-2016-313099.
47. Pérez-Cobas AE, Gosalbes MJ, Friedrichs A et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 2013; 62: 1591–1601.
48. Korpela K, Salonen A, Virta LJ, Kekkonen RA, de Vos WM. Association of early-life antibiotic use and protective effects of breastfeeding: Role of the intestinal microbiota. JAMA Pediatr 2016; 170: 750–757.
49. Mahana D, Trent CM, Kurtz ZD et al. Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet. Genome Med 2016; 8: 48.
50. Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med 2016; 39.
51. Kootte RS, Vrieze A, Holleman F et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 2012; 14: 112–120.
52. Knoop KA, McDonald KG, Kulkarni DH, Newberry RD. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut 2016; 65: 1100–1109.
53. Fujisaka S, Ussar S, Clish C et al. Antibiotic effects on gut microbiota and metabolism are host dependent. J Clin Invest 2016; 126: 4430–4443.
54. Raymond F, Ouameur AA, Déraspe M et al. The initial state of the human gut microbiome determines its reshaping by antibiotics. ISME J 2016; 10: 707–720.
55. Reijnders D, Goossens Gijs H, Hermes Gerben DA et al. Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans: a randomized double-blind placebo-controlled trial. Cell Metab 2016; 24: 63–74.
56. Xu C, Yan M, Sun Y et al. Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population. Helicobacter 2014; 19: 437–442.
57. Zhang Y, Du T, Chen X, Yu X, Tu L, Zhang C. Association between Helicobacter pylori infection and overweight or obesity in a Chinese population. J Infect Dev Ctries 2015: 945–953.
58. Khusnutdinova D, Grigoryeva T, Abdulkhakov S et al. Gut microbiome shotgun sequencing in assessment of microbial community changes associated with H. pylori eradication therapy. BioNanoScience 2016; 6: 585–587.
59. Xu W-T, Nie Y-Z, Yang Z, Lu N-H. The crosstalk between gut microbiota and obesity and related metabolic disorders. Future Microbiol 2016; 11: 825–836.
60. John GK, Mullin GE. The gut microbiome and obesity. Curr Oncol Rep 2016; 18: 45.
61. Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010; 156: 3216–3223.
62. Varankovich NV, Nickerson MT, Korber DR. Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases. Front Microbiol 2015; 685.
63. Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761–1772.
64. Cani PD, Neyrinck AM, Fava F et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50: 2374–2383.
65. Sánchez B, Delgado S, Blanco-Míguez A, Lourenço A, Gueimonde M, Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res 2017; 61 1600240-n/a.
66. Rouxinol-Dias AL, Pinto AR, Janeiro C et al. Probiotics for the control of obesity – its effect on weight change. Porto Biomed J 2016; 1: 12–24.
67. Wang J, Tang H, Zhang C et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 2015; 9: 1–15.
68. Zoumpopoulou G, Pot B, Tsakalidou E, Papadimitriou K. Dairy probiotics: beyond the role of promoting gut and immune health. Int Dairy J 2017; 67: 46–60.
69. Anselmo AC, McHugh KJ, Webster J, Langer R, Jaklenec A. Layer-by-layer encapsulation of probiotics for delivery to the microbiome. Adv Mater 2016; 28: 9486–9490.
70. Li W, Zhu Y, Ye F, Li B, Luo X, Liu S. Probiotics in cellulose houses: enhanced viability and targeted delivery of Lactobacillus plantarum. Food Hydrocoll 2017; 62: 66–72.
71. Yoo JY, Kim SS. Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Nutrients 2016; 8: 173.
72. Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2015; 12: 303–310.
73. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 2015; 11: 577–591.
74. Maldonado-Gómez María X, Martínez I, Bottacini F et al. Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe 2016; 20: 515–526.
75. Zhang C, Derrien M, Levenez F et al. Ecological robustness of the gut microbiota in response to ingestion of transient food-borne microbes. ISME J 2016; 10: 2235–2245.
76. Finelli C, Padula MC, Martelli G, Tarantino G. Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol 2014; 20: 16649–16664.
77. Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol 2017; 14: 160–169.
78. Hankir MK, Seyfried F, Hintschich CA et al. Gastric bypass surgery recruits a gut PPAR-α-striatal D1R pathway to reduce fat appetite in obese rats. Cell Metab 2017; 25: 335–344.
79. Guyton K, Alverdy JC. The gut microbiota and gastrointestinal surgery. Nat Rev Gastroenterol Hepatol 2017; 14: 43–54.
80. Saltiel AR. New therapeutic approaches for the treatment of obesity. Sci Transl Med 2016; 8 323rv322.
81. Tremaroli V, Karlsson F, Werling M et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 2015; 22: 228–238.
82. Nehra V, Allen JM, Mailing LJ, Kashyap PC, Woods JA. Gut microbiota: modulation of host physiology in obesity. Physiology (Bethesda) 2016; 31: 327–335.
83. Zhang H, DiBaise JK, Zuccolo A et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 2009; 106: 2365–2370.
84. Marotz CA, Zarrinpar A. Treating obesity and metabolic syndrome with fecal microbiota transplantation. Yale J Biol Med 2016: 383–388.
85. Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol 2016; 13: 508–516.
86. Vrieze A, Van Nood E, Holleman F et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143 913-916.e917.
87. Bojanova DP, Bordenstein SR. Fecal transplants: what is being transferred? PLoS Biol 2016; e1002503.
88. Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep 2013; 15: 337.
89. Alang N, Kelly CR. Weight gain after fecal microbiota transplantation. Open Forum Infect Dis 2015; ofv004.
90. Kulecka M, Paziewska A, Zeber-Lubecka N et al. Prolonged transfer of feces from the lean mice modulates gut microbiota in obese mice. Nutr Metab (Lond) 2016; 57.
91. Harris JW, Brown JH. The bacterial content of the uterus at cesarean section. II. Am J Obstet Gynecol 1928; 16: 332–338.
92. DiGiulio DB, Romero R, Kusanovic JP et al. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol 2010; 64: 38–57.
93. Verstraelen H, Vilchez-Vargas R, Desimpel F et al. Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene. PeerJ 2016; e1602.
94. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 2014; 6: 237ra265.
95. Pelzer E, Gomez-Arango LF, Barrett HL, Nitert MD. Maternal health and the placental microbiome. Placenta.
96. Stinson LF, Payne MS, Keelan JA. Planting the seed: origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota. Crit Rev Microbiol 2016: 1–18.
97. Hansen R, Scott KP, Khan S et al. First-pass meconium samples from healthy term vaginally-delivered neonates: an analysis of the microbiota. PLoS One 2015; e0133320.
98. Bäckhed F, Roswall J, Peng Y et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015; 17: 690–703.
99. Smith J, Cianflone K, Biron S et al. Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab. 2009; 94: 4275–4283.
100. Godfrey KM, Reynolds RM, Prescott SL et al. Influence of maternal obesity on the long-term health of offspring. Lancet Diabetes Endocrinol; 5: 53–64.
101. Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. Nature 2016; 529: 212–215.
102. Dominguez-Bello MG, De Jesus-Laboy KM, Shen N et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 2016; 22: 250–253.
103. Locke AE, Kahali B, Berndt SI et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015; 518: 197–206.
104. Blekhman R, Goodrich JK, Huang K et al. Host genetic variation impacts microbiome composition across human body sites. Genome Biol 2015; 191.
105. Karpe F, Lindgren CM. Obesity – on or off? N Engl J Med 2016; 374: 1486–1488.
106. Walley AJ, Asher JE, Froguel P. The genetic contribution to non-syndromic human obesity. Nat Rev Genet 2009; 10: 431–442.
107. Thorleifsson G, Walters GB, Gudbjartsson DF et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009; 41: 18–24.
108. Dalgaard K, Landgraf K, Heyne S et al. Trim28 haploinsufficiency triggers bi-stable epigenetic obesity. Cell 2016; 164: 353–364.
109. Arif A, Terenzi F, Potdar AA et al. EPRS is a critical mTORC1–S6K1 effector that influences adiposity in mice. Nature 2017; 542: 357–361.
110. Abdul-Aziz MA, Cooper A, Weyrich LS. Exploring relationships between host genome and microbiome: new insights from genome-wide association studies. Front Microbiol 2016; 7: 1611.
111. Goodrich JK, Davenport ER, Waters JL, Clark AG, Ley RE. Cross-species comparisons of host genetic associations with the microbiome. Science 2016; 352: 532.
112. Goodrich Julia K, Waters Jillian L, Poole Angela C et al. Human genetics shape the gut microbiome. Cell 2014; 159: 789–799.
113. Della Torre S, Maggi A. Sex differences: a resultant of an evolutionary pressure? Cell Metab 2017; 25: 499–505.
114. Lovejoy JC, Sainsbury A, Stock Conference Working G. Sex differences in obesity and the regulation of energy homeostasis. Obes Rev 2009; 10: 154–167.
115. Hwang L-L, Wang C-H, Li T-L et al. Sex differences in high-fat diet-induced obesity, metabolic alterations and learning, and synaptic plasticity deficits in mice. Obesity 2010; 18: 463–469.
116. Jašarević E, Morrison KE, Bale TL. Sex differences in the gut microbiome–brain axis across the lifespan. Philos Trans R Soc Lond B Biol Sci 2016; 371: 20150122.
117. Bolnick DI, Snowberg LK, Hirsch PE et al. Individual diet has sex-dependent effects on vertebrate gut microbiota. Nat Commun 2014; 5: 4500.
118. Liang X, Bushman FD, Fitzgerald GA. Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock. Proc Nat Acad Sci 2015; 112: 10479.
119. Rampelli S, Candela M, Turroni S et al. Functional metagenomic profiling of intestinal microbiome in extreme ageing. Aging (Albany NY) 2013; 5: 902–912.
120. Biagi E, Candela M, Turroni S, Garagnani P, Franceschi C, Brigidi P. Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol Res 2013; 69: 11–20.
121. Franceschi C. Healthy ageing in 2016: obesity in geroscience [mdash] is cellular senescence the culprit? Nat Rev Endocrinol 2017; 13: 76–78.
122. Paolella G, Vajro P. Childhood obesity, breastfeeding, intestinal microbiota, and early exposure to antibiotics: what is the link? JAMA Pediatr 2016; 170: 735–737.
123. Candela M, Biagi E, Maccaferri S, Turroni S, Brigidi P. Intestinal microbiota is a plastic factor responding to environmental changes. Trends Microbiol 2012; 20: 385–391.
124. De Filippo C, Cavalieri D, Di Paola M et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010; 107: 14691–14696.
125. Hehemann J-H, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010; 464: 908–912.
126. Lax S, Nagler CR, Gilbert JA. Our interface with the built environment: immunity and the indoor microbiota. Trends Immunol 2015; 36: 121–123.
127. Mensah-Attipoe J, Täubel M, Hernandez M, Pitkäranta M, Reponen T. An emerging paradox: toward a better understanding of the potential benefits and adversity of microbe exposures in the indoor environment. Indoor Air 2017; 27: 3–5.
128. Broussard JL, Devkota S. The changing microbial landscape of Western society: diet, dwellings and discordance. Mol Metab 2016; 5: 737–742.
129. Peccia J, Kwan SE. Buildings, beneficial microbes, and health. Trends Microbiol 2016; 24: 595–597.
130. Beans C. The microbiome of green design sustainable building practices may have unforeseen consequences for microbial communities and human health. BioScience 2016; 66: 801–806.
131. Zhernakova A, Kurilshikov A, Bonder MJ et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 2016; 352: 565.
132. Chevalier C, Stojanović O, Colin Didier J et al. Gut microbiota orchestrates energy homeostasis during cold. Cell 2015; 163: 1360–1374.
133. Ziętak M, Kovatcheva-Datchary P, Markiewicz LH, Ståhlman M, Kozak LP, Bäckhed F. Altered microbiota contributes to reduced diet-induced obesity upon cold exposure. Cell Metab 2016; 23: 1216–1223.
134. Eriksson C, Hilding A, Pyko A, Bluhm G, Pershagen G, Östenson C-G. Long-term aircraft noise exposure and body mass index, waist circumference, and type 2 diabetes: a prospective study. Environ Health Perspect 2014; 122: 687–694.
135. Christensen JS, Raaschou-Nielsen O, Tjønneland A et al. Road traffic and railway noise exposures and adiposity in adults: a cross-sectional analysis of the Danish diet, cancer, and health cohort. Environ Health Perspect 2016; 124: 329–335.
136. Cui B, Gai Z, She X, Wang R, Xi Z. Effects of chronic noise on glucose metabolism and gut microbiota-host inflammatory homeostasis in rats. Sci Rep 2016; 36693.
137. Chen L, Zhang Y-H, Huang T, Cai Y-D. Gene expression profiling gut microbiota in different races of humans. Sci Rep 2016; 23075.
138. Li L, Zhao X. Comparative analyses of fecal microbiota in Tibetan and Chinese Han living at low or high altitude by barcoded 454 pyrosequencing. Sci Rep 2015; 5: 14682.
139. Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science 2016; 352: 544.
140. Kang SS, Jeraldo PR, Kurti A et al. Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition. Mol Neurodegener 2014; 9: 36–36.
141. McHill AW, Melanson EL, Higgins J et al. Impact of circadian misalignment on energy metabolism during simulated nightshift work. Proc Natl Acad Sci U S A. 2014; 111: 17302–17307.
142. Thaiss Christoph A, Zeevi D, Levy M et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. 2014; 159: 514–529.
143. Barroso E, Muñoz-González I, Jiménez E et al. Phylogenetic profile of gut microbiota in healthy adults after moderate intake of red wine. Mol Nutr Food Res 2017; 61 1600620-n/a.
144. Sze MA, Schloss PD. Looking for a signal in the noise: revisiting obesity and the microbiome. MBio 2016.
145. Li D-K, Chen H, Ferber J, Odouli R. Infection and antibiotic use in infancy and risk of childhood obesity: a longitudinal birth cohort study. Lancet Diabetes Endocrinol 2017; 5: 18–25.
146. Forrest CB, Block JP, Bailey LC. Antibiotics, infections, and childhood obesity. Lancet Diabetes Endocrinol 2017; 5: 2–3.
147. Schwarz-Romond T. Microbiota: ‘bugging’ insights into metabolic regulation. Mol Metab 2016; 5: iv–iv.
148. Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480–484.
149. Santacruz A, Collado MC, García-Valdés L et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 2010; 104: 83–92.
150. Everard A, Belzer C, Geurts L et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 2013; 110: 9066–9071.
151. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJM, Relman DA. The application of ecological theory toward an understanding of the human microbiome. Science 2012; 336: 1255.
152. Ridaura VK, Faith JJ, Rey FE et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (New York, NY) 2013; 341 1241214.
153. Shade A. Diversity is the question, not the answer. ISME J 2017; 11: 1–6.
154. White Iii RA, Callister SJ, Moore RJ, Baker ES, Jansson JK. The past, present and future of microbiome analyses. Nat Protocols 2016; 11: 2049–2053.
155. Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med 2016; 51.
156. Pamer EG. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science 2016; 352: 535.
157. Berry D. Making it stick: a compelling case for precision microbiome reconstitution. Cell Host Microbe 2016; 20: 415–417.
158. Zmora N, Zeevi D, Korem T, Segal E, Elinav E. Taking it personally: personalized utilization of the human microbiome in health and disease. Cell Host Microbe 2016; 19: 12–20.